GlassScriptPhysician profile
Martin Riss
NPI 1548276827
$5,767.18
in general payments reported to CMS, 2019-2025
40 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $905 · 2021: $970 · 2022: $955 · 2023: $1,008 · 2024: $727 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,008.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $757.45 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $709.02 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Pfizer INC. | $530.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $529.35 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $348.44 | 2019-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $211.36 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.47 | 2020-2023 | Jardiance |
| Abbott Laboratories | $116.23 | 2022-2024 | Freestyle Libre 3 |
| Boston Scientific Corporation | $114.41 | 2019-2022 | |
| Amarin Pharma, INC. | $114.01 | 2019-2020 | |
| Astellas Pharma US INC | $109.20 | 2019-2023 | Veozah |
| Exact Sciences Corporation | $104.75 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.71 | 2019-2024 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $72.88 | 2023 | Quviviq |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Riss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.